1. Home
  2. YCBD vs NBY Comparison

YCBD vs NBY Comparison

Compare YCBD & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YCBD
  • NBY
  • Stock Information
  • Founded
  • YCBD 2015
  • NBY 2000
  • Country
  • YCBD United States
  • NBY United States
  • Employees
  • YCBD N/A
  • NBY N/A
  • Industry
  • YCBD Biotechnology: Pharmaceutical Preparations
  • NBY
  • Sector
  • YCBD Health Care
  • NBY
  • Exchange
  • YCBD Nasdaq
  • NBY Nasdaq
  • Market Cap
  • YCBD 7.8M
  • NBY 6.3M
  • IPO Year
  • YCBD N/A
  • NBY 2007
  • Fundamental
  • Price
  • YCBD $0.88
  • NBY $1.18
  • Analyst Decision
  • YCBD Strong Buy
  • NBY Strong Buy
  • Analyst Count
  • YCBD 1
  • NBY 1
  • Target Price
  • YCBD $2.00
  • NBY $0.85
  • AVG Volume (30 Days)
  • YCBD 608.2K
  • NBY 421.8K
  • Earning Date
  • YCBD 12-17-2025
  • NBY 11-10-2025
  • Dividend Yield
  • YCBD N/A
  • NBY N/A
  • EPS Growth
  • YCBD N/A
  • NBY N/A
  • EPS
  • YCBD N/A
  • NBY 0.41
  • Revenue
  • YCBD $19,026,064.00
  • NBY $9,781,000.00
  • Revenue This Year
  • YCBD $0.37
  • NBY $23.91
  • Revenue Next Year
  • YCBD $4.95
  • NBY $32.05
  • P/E Ratio
  • YCBD N/A
  • NBY $3.03
  • Revenue Growth
  • YCBD N/A
  • NBY 113.47
  • 52 Week Low
  • YCBD $0.59
  • NBY $0.46
  • 52 Week High
  • YCBD $6.54
  • NBY $4.44
  • Technical
  • Relative Strength Index (RSI)
  • YCBD 40.93
  • NBY 45.26
  • Support Level
  • YCBD $0.94
  • NBY $1.17
  • Resistance Level
  • YCBD $1.09
  • NBY $1.31
  • Average True Range (ATR)
  • YCBD 0.13
  • NBY 0.14
  • MACD
  • YCBD -0.05
  • NBY 0.02
  • Stochastic Oscillator
  • YCBD 5.27
  • NBY 44.62

About YCBD cbdMD Inc.

cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.

About NBY NovaBay Pharmaceuticals Inc.

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.

Share on Social Networks: